BMJ 1995;310:1360-1362 (27 May)
Papers
Oral versus intravenous antibiotics for community acquired lower respiratory tract infection in a general hospital: open, randomised controlled trial
Robert Chan,
research registrar,a
Linda Hemeryck,
research nurse,a
Myra O'Regan,
lecturer,b
Luke Clancy,
. consultant physician,c
John Feely,
professor aa Department of Therapeutics and Medicines Evaluation Unit, Trinity Centre for Health Sciences, St James's Hospital, Dublin 8,
b Department of Statistics, Trinity Centre for Health Sciences,
c Department of Respiratory Medicine, Trinity Centre for Health Sciences
Correspondence to: Professor Feely, department of pharmacology and therapeutics.
Abstract
Objective: To see whether there is a difference in outcome between patients treated with oral and intravenous antibiotics for lower respiratory tract infection.
Design: Open controlled trial in patients admitted consecutively and randomised to treatment with either oral co-amoxiclav, intravenous followed by oral co-amoxiclav, or intravenous followed by oral cephalosporins.
Setting: Large general hospital in Dublin.
Patients: 541 patients admitted for lower respiratory tract infection during one year. Patients represented 87% of admissions with the diagnosis and excluded those who were immunocompromised and patients with severe life threatening infection.
Main outcome measures: Cure, partial cure, extended antibiotic treatment, change of antibiotic, death, and cost and duration of hospital stay.
Results: There were no significant differences between the groups in clinical outcome or mortality (6%). However, patients randomised to oral coamoxiclav had a significantly shorter hospital stay than the two groups given intravenous antibiotic (median 6 v 7 and 9 days respectively). In addition, oral antibiotics were cheaper, easier to administer, and if used routinely in the 800 or so patients admitted annually would lead to savings of around pounds sterling176000 a year.
Conclusions: Oral antibiotics in community acquired lower respiratory tract infection are at least as efficacious as intravenous therapy. Their use reduces labour and equipment costs and may lead to earlier discharge from hospital.
|
Key messages
- Key messages
- In patients who are not immunocompromised and do not have severe life threatening infections --that is, most--co-amoxiclav by the oral route is as effective as intravenous co-amoxiclav or third generation cephalosporins
- Oral treatment is easier to administer, cheaper, and associated with earlier discharge from hospital
- The continued routine use of intravenous antibiotics in these patients cannot be justified
|

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Relevant Article
-
Oral versus intravenous antibiotics
- Peter Tsang
BMJ 1995 311: 685.
[Extract]
[Full Text]
This article has been cited by other articles:
-
Lim, W S, Baudouin, S V, George, R C, Hill, A T, Jamieson, C, Le Jeune, I, Macfarlane, J T, Read, R C, Roberts, H J, Levy, M L, Wani, M, Woodhead, M A, Pneumonia Guidelines Committee of the BTS Standard,
(2009). BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax
64: iii1-iii55
[Full text]
-
McLaughlin, C.M., Bodasing, N., Boyter, A.C., Fenelon, C., Fox, J.G., Seaton, R.A.
(2005). Pharmacy-implemented guidelines on switching from intravenous to oral antibiotics: an intervention study. QJM
98: 745-752
[Abstract]
[Full text]
-
Vogtlander, N. P. J., van Kasteren, M. E. E., Natsch, S., Kullberg, B.-J., Hekster, Y. A., van der Meer, J. W. M.
(2004). Improving the Process of Antibiotic Therapy in Daily Practice: Interventions to Optimize Timing, Dosage Adjustment to Renal Function, and Switch Therapy. Arch Intern Med
164: 1206-1212
[Abstract]
[Full text]
-
Waitt, C, Waitt, P, Pirmohamed, M
(2004). Intravenous therapy. Postgrad. Med. J.
80: 1-6
[Abstract]
[Full text]
-
Halm, E. A., Teirstein, A. S.
(2002). Management of Community-Acquired Pneumonia. NEJM
347: 2039-2045
[Full text]
-
Ortqvist, A.
(2002). Treatment of community-acquired lower respiratory tract infections in adults. Eur Respir J
20: 40S-53s
[Abstract]
[Full text]
-
Ferner, R.E.
(2002). Medicines management: a sour taste. QJM
95: 181-184
[Full text]
-
(2001). BTS Guidelines for the Management of Community Acquired Pneumonia in Adults. Thorax
56: iv1-64
[Full text]
-
Al-Eidan, F. A., McElnay, J. C., Scott, M. G., Kearney, M. P., Corrigan, J., McConnell, J. B.
(2000). Use of a treatment protocol in the management of community-acquired lower respiratory tract infection. J Antimicrob Chemother
45: 387-394
[Abstract]
[Full text]
-
Sevinc, F., Prins, J. M., Koopmans, R. P., Langendijk, P. N. J., Bossuyt, P. M., Dankert, J., Speelman, P.
(1999). Early switch from intravenous to oral antibiotics: guidelines and implementation in a large teaching hospital. J Antimicrob Chemother
43: 601-606
[Abstract]
[Full text]
-
Fraser, G. L., Stogsdill, P., Dickens, J. D. Jr, Wennberg, D. E., Smith, R. P. Jr, Prato, B. S.
(1997). Antibiotic Optimization: An Evaluation of Patient Safety and Economic Outcomes. Arch Intern Med
157: 1689-1694
[Abstract]
-
Nathwani, D., Boyter, A., Fegan, P. G., Davey, P.
(1996). Switch Therapy in Community-Acquired Pneumonia. Arch Intern Med
156: 1235-1235
[Abstract]
-
Tsang, P.
(1995). Oral versus intravenous antibiotics. BMJ
311: 685a-685
[Full text]
-
(1995). ORAL ANTIBIOTICS WORK WELL FOR LOWER RESPIRATORY INFECTIONS. JWatch General
1995: 3-3
[Full text]